Champions Oncology, Inc. (NASDAQ:CSBR) Q3 2025 Earnings Call Transcript March 11, 2025
Champions Oncology, Inc. beats earnings expectations. Reported EPS is $0.3181, expectations were $0.06.
Operator: Greetings. Welcome to the Champions Oncology Third Quarter Fiscal Year 2025 Earnings Call [Operator Instructions]. Please note, this conference is being recorded. I will now turn the conference over to your host, Ronnie Morris, Chief Executive Officer. You may begin.
Ronnie Morris: Good...
